BE550548A - - Google Patents
Info
- Publication number
- BE550548A BE550548A BE550548DA BE550548A BE 550548 A BE550548 A BE 550548A BE 550548D A BE550548D A BE 550548DA BE 550548 A BE550548 A BE 550548A
- Authority
- BE
- Belgium
- Prior art keywords
- clupeine
- methyl
- metaphosphate
- product
- ester
- Prior art date
Links
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 18
- 238000000034 method Methods 0.000 claims description 14
- 108010040512 Clupeine Proteins 0.000 claims description 11
- 239000000243 solution Substances 0.000 claims description 10
- 108010007568 Protamines Proteins 0.000 claims description 8
- 102000007327 Protamines Human genes 0.000 claims description 8
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 7
- 238000002360 preparation method Methods 0.000 claims description 7
- 229940048914 protamine Drugs 0.000 claims description 6
- 238000001816 cooling Methods 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- 238000010253 intravenous injection Methods 0.000 claims description 2
- 241000782012 Clupei Species 0.000 claims 1
- 238000001035 drying Methods 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 238000005406 washing Methods 0.000 claims 1
- 239000000047 product Substances 0.000 description 8
- 238000001990 intravenous administration Methods 0.000 description 7
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 6
- 125000005341 metaphosphate group Chemical group 0.000 description 6
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical group OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 5
- 229910021653 sulphate ion Inorganic materials 0.000 description 5
- 239000002253 acid Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- 241000252203 Clupea harengus Species 0.000 description 2
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 2
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 2
- 239000003929 acidic solution Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 108010016290 deoxyribonucleoprotamine Proteins 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 229960002897 heparin Drugs 0.000 description 2
- 229920000669 heparin Polymers 0.000 description 2
- 235000019514 herring Nutrition 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 230000014508 negative regulation of coagulation Effects 0.000 description 2
- 229940070353 protamines Drugs 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 230000001698 pyrogenic effect Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 102000005237 Isophane Insulin Human genes 0.000 description 1
- 108010081368 Isophane Insulin Proteins 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 229940075930 picrate Drugs 0.000 description 1
- OXNIZHLAWKMVMX-UHFFFAOYSA-M picrate anion Chemical class [O-]C1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-M 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 235000011121 sodium hydroxide Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE550548A true BE550548A (enrdf_load_stackoverflow) |
Family
ID=176391
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE550548D BE550548A (enrdf_load_stackoverflow) |
Country Status (1)
| Country | Link |
|---|---|
| BE (1) | BE550548A (enrdf_load_stackoverflow) |
-
0
- BE BE550548D patent/BE550548A/fr unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BE550548A (enrdf_load_stackoverflow) | ||
| CH642047A5 (fr) | Procede de fabrication de l'acide parahydroxymandelique racemique. | |
| EP2173701A1 (fr) | Procede de preparation du fenofibrate | |
| CH635588A5 (fr) | Procedes de preparation de thieno(2,3-c) et thieno(3,2-c)pyridines. | |
| EP0221815B1 (fr) | Procédé pour la fabrication d'acides alkanoiques | |
| FR2475536A2 (fr) | Procede de preparation de l'acide di-n-propylacetique et de ses sels de metaux alcalins | |
| BE500594A (enrdf_load_stackoverflow) | ||
| EP0497065B1 (fr) | Procédé industriel de préparation de dérivés phosphoniques de vinblastine | |
| CA1095051A (fr) | Preparation du chlorhydrate de n-nicotinoyl o-p- chloro phenoxy isobutanoly ethanol amine | |
| BE445556A (fr) | Procédé pour la préparation, à l'état pur, d'acides aminocarboniques à partir d'oximes | |
| EP0058111B1 (fr) | 5-acétyloxy-L-tryptophane et ses sels d'addition, procédé de préparation et utilisation en thérapeutique | |
| BE817776Q (fr) | Nouveaux derives de 5-phenyl-tetrazoles | |
| CH396030A (fr) | Procédé de préparation de la N-isopropyl-N-benzyl-hydrazine et ses sels | |
| BE421682A (enrdf_load_stackoverflow) | ||
| FR2918662A1 (fr) | Procede de preparation du fenofibrate | |
| PL40842B1 (enrdf_load_stackoverflow) | ||
| FR2580645A1 (fr) | Procede de preparation du nitro-6 naphto(1,8-c, d)oxathiole-1,2 dioxyde-2,2 | |
| BE552216A (enrdf_load_stackoverflow) | ||
| CH402842A (fr) | Procédé de préparation de nouveaux dérivés de l'héparine | |
| CH370093A (fr) | Procédé pour la préparation de dérivés de l'acide diamino-caproïque | |
| CH336832A (fr) | Procédé de préparation de sulfonamides hétérocycliques substitués | |
| BE630064A (enrdf_load_stackoverflow) | ||
| CH298379A (fr) | Procédé de préparation de l'allo-1-p-nitrophényl-2-(ortho-carboxybenzoyl)-amino-propanediol-1,3. | |
| FR2529203A1 (fr) | Procede industriel d'obtention et de purification de flunitrazepam de qualite pharmaceutique | |
| CH91560A (fr) | Procédé pour la préparation de la vanilline. |